Bharat Parenterals Ltd - Stock Valuation and Financial Performance

BSE: 541096 | NSE: | Pharmaceuticals & Drugs | Small Cap

Bharat Parenterals Share Price

1,518.25 -79.90 -5.00%
as on 07-Oct'24 16:01

DeciZen - make an informed investing decision on Bharat Parenterals

Overall Rating
Bole Toh

1. Quality

2. Valuation

Overvalued

3. Price Trend

Bharat Parenterals stock performance -

mw4me loader
P/E Ratio (SA):
38.28
Market Cap:
990.6 Cr.
52-wk low:
513.2
52-wk high:
1,854

Is Bharat Parenterals Ltd an attractive stock to invest in?

1. Is Bharat Parenterals Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Bharat Parenterals Ltd is a average quality company.

2. Is Bharat Parenterals Ltd undervalued or overvalued?

The key valuation ratios of Bharat Parenterals Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Bharat Parenterals Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Bharat Parenterals Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Bharat Parenterals:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Bharat Parenterals Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % 16.7%15.2%12.1%19.2%39.8%31.7%19.8%17.6%16.6%13%-
Value Creation
Index
0.20.1-0.10.41.91.30.40.30.2-0.1-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 119124111136220226204212218254276
Sales YoY Gr.-4.5%-10.4%22.6%61.2%3%-10%4.1%2.8%16.6%-
Adj EPS 12.811.511.41436.342.434.336.129.235.339.7
YoY Gr.--9.8%-1.6%23.6%158.8%16.6%-19.1%5.4%-19.1%20.7%-
BVPS (₹) 87.399112129.7169214.9250.5287.7329.9367.1492.6
Adj Net
Profit
7.36.66.5820.824.319.620.916.920.526
Cash Flow from Ops. 9.40-1.96.320.314.521.9-22.1-11.6-22.9-
Debt/CF from Ops. 1.70-3.41.40.20.10.6-0.7-4-3.6-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 8.8%3%7.7%16.6%
Adj EPS 11.9%-0.6%1%20.7%
BVPS17.3%16.8%13.6%11.3%
Share Price - 52.9% 59.6% 168.7%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
15.812.410.811.624.322.114.713.59.510.29.2
Op. Profit
Mgn %
9.28.36.39.713.813.412.313.81011.511.6
Net Profit
Mgn %
6.25.35.95.99.510.79.69.87.78.19.4
Debt to
Equity
0.30.30.10.10.100.10.10.20.4-
Working Cap
Days
215220229223169200189199276337150
Cash Conv.
Cycle
484653827688819011314440

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to 9.20%

Sales growth has been subdued in last 3 years 7.66%

Net Profit has been subdued in last 3 years 0.98%

Sales growth is not so good in last 4 quarters at 8.28%

Latest Financials - Bharat Parenterals Ltd.

Standalone Consolidated
TTM EPS (₹) 39.7 12.7
TTM Sales (₹ Cr.) 276 280
BVPS (₹.) 492.6 435.3
Reserves (₹ Cr.) 315 278
P/BV 3.08 3.49
PE 38.28 119.63
From the Market
52 Week Low / High (₹) 513.15 / 1854.00
All Time Low / High (₹) 116.25 / 1854.00
Market Cap (₹ Cr.) 991
Equity (₹ Cr.) 6.5
Face Value (₹) 10
Industry PE 47

Management X-Ray of Bharat Parenterals:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Bharat Parenterals

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales119124111136220226204212218254
Operating Expenses 108114104123190197179184196225
Manufacturing Costs3668121210111517
Material Costs86837988141147134136137158
Employee Cost 791112141414151720
Other Costs 1116815222320212730
Operating Profit 1110713303025282229
Operating Profit Margin (%) 9.2%8.0%6.3%9.6%13.7%13.2%12.3%13.4%9.9%11.5%
Other Income 45871312981912
Interest 2111111134
Depreciation 4466666766
Exceptional Items 0000000000
Profit Before Tax 99814363527283231
Tax 13141397788
Profit After Tax 76710232620212423
PAT Margin (%) 6.3%5.2%6.6%7.4%10.3%11.6%9.9%10.0%11.2%8.9%
Adjusted EPS (₹)13.011.312.917.639.445.935.336.942.138.8
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%2%3%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 5057647497123144166191214
Share Capital 6666666666
Reserves 4451586991117138160185208
Minority Interest0000000000
Debt1619473110134380
Long Term Debt127421191074
Short Term Debt5130520133676
Trade Payables44393626324326234853
Others Liabilities 65623302617172741
Total Liabilities 116120110131161192196218308387

Fixed Assets

Gross Block53623644505471737482
Accumulated Depreciation2428510162228333943
Net Fixed Assets29353134343243403538
CWIP 00001120100
Investments 11113242163849
Inventories13141514212822213854
Trade Receivables5844445966826873112140
Cash Equivalents 1132412102573
Others Assets141418192427196377103
Total Assets 116120110131161192196218308387

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity 90-26201422-22-12-23
PBT 90814363527283231
Adjustment 6066766515
Changes in Working Capital -40-14-11-12-17-4-49-36-49
Tax Paid -20-2-3-10-10-7-6-9-10
Cash Flow From Investing Activity -50-2-8-9-13-4122-14-16
Capex -50-2-8-9-151-55-10
Net Investments 0000-11-4127-22-10
Others 0010010034
Cash Flow From Financing Activity -70-84-4-31122934
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 000000101-3-3
Interest Paid -20-1-1-1-10-1-2-3
Dividend Paid 0000000000
Others -50-75-3-2123341
Net Cash Flow -20-1127-1-823-5
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)16.0412.112.2114.5926.3823.9215.1613.7613.6511.18
ROCE (%)16.6515.2112.0919.1539.8331.6819.817.5916.6213.02
Asset Turnover Ratio1.21.111.031.151.51.281.221.160.960.82
PAT to CFO Conversion(x)1.290-0.290.60.870.541.1-1.05-0.5-1
Working Capital Days
Receivable Days137142136136103119115107134162
Inventory Days40384539303939334259
Payable Days1541831731307592946594117

Bharat Parenterals Ltd Stock News

Bharat Parenterals Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Bharat Parenterals on 07-Oct-2024 16:01 is ₹1,518.3.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 07-Oct-2024 16:01 the market cap of Bharat Parenterals stood at ₹990.6.
The latest P/E ratio of Bharat Parenterals as of 07-Oct-2024 16:01 is 38.28.
The latest P/B ratio of Bharat Parenterals as of 07-Oct-2024 16:01 is 3.08.
The 52-week high of Bharat Parenterals is ₹1,854 and the 52-week low is ₹513.1.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Bharat Parenterals is ₹276.3 ( Cr.) .

About Bharat Parenterals Ltd

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.